Top Markets
Coin of the day
Sartorius Aktiengesellschaft Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

SOAGY
Clasificación en acciones #317
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and... Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Precio por acción
$47.54
Capitalización bursátil
$69.46B
Cambio (1 día)
-3.59%
Cambio (1 año)
-9.07%
País
DE
Comercio Sartorius Aktiengesellschaft (SOAGY)

Categoría

Ganancias de Sartorius Aktiengesellschaft (SOAGY)
Ganancias en Dec 2025 TTM: $394.38M
Secondo gli ultimi rapporti finanziari di Sartorius Aktiengesellschaft, gli utili attuali della società sono $394.38M. Nel 2023, la società ha registrato un utile di $426.71M, una disminución en comparación con agli utili del 2022, che erano di $1.27B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Sartorius Aktiengesellschaft desde 2002 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $394.38M 102.89%
2024 $194.38M -54.45%
2023 $426.71M -66.34%
2022 $1.27B 66.77%
2021 $760.07M 46.93%
2020 $517.29M 52.17%
2019 $339.95M 9.28%
2018 $311.07M 28.86%
2017 $241.40M 12.41%
2016 $214.76M 14.73%
2015 $187.18M 60.76%
2014 $116.43M -11.24%
2013 $131.18M 5.88%
2012 $123.90M 21.09%
2011 $102.33M 22.03%
2010 $83.85M 469.25%
2009 $14.73M -60.63%
2008 $37.42M -37.89%
2007 $60.25M -0.18%
2006 $60.35M 45.20%
2005 $41.57M 10.05%
2004 $37.77M 214.76%
2003 $12.00M 52.12%
2002 $7.89M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$3.31B 739.65%
US
$2.06B 423.10%
US
$2.05B 418.94%
JP
$1.16B 194.13%
CH
$1.82B 361.15%
US